In this article uMed’s CEO Matt Wilson discusses the untapped potential of harnessing data-led insights to drive personalized, meaningful consumer experiences within the healthcare sector. He examines how tailored communication and bespoke engagement throughout a patient’s healthcare journey has the potential to enhance health outcomes and reduce provider costs. And how it’s the key to opening up better engagement with clinical trials, new drugs and treatments, encouraging healthier behaviors and building trust with healthcare customers.

Read the full article here: Read Article

A great article from our CEO Matt Wilson featured in The Journal of mHealth on the use of technology to address the challenges of access to clinical trial participation in underserved communities.

The article emphasizes the need to support smaller, local healthcare providers that serve as a gateway to underrepresented, less wealthy communities, to build trust and address the disparity in clinical trial participation.

Using technology can alleviate the organizational burden of clinical trials on these smaller providers, and embed recruitment in routine practice.

Additionally, technology provides opportunity for tailored patient outreach and the inclusion of non-English speakers, ultimately democratizing research and promoting diversity.

Read the full article here.